These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 23856575)

  • 21. Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders.
    Griffin D; Benadiva C; Kummer N; Budinetz T; Nulsen J; Engmann L
    Fertil Steril; 2012 Jun; 97(6):1316-20. PubMed ID: 22480822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrieval of zona-free immature oocytes in a woman with recurrent empty follicle syndrome: a case report.
    Duru NK; Cincik M; Dede M; Hasimi A; Baser I
    J Reprod Med; 2007 Sep; 52(9):858-63. PubMed ID: 17939607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of endogenous luteinizing hormone serum levels on progesterone elevation on the day of human chorionic gonadotropin administration.
    Hugues JN; Massé-Laroche E; Reboul-Marty J; Boîko O; Meynant C; Cédrin-Durnerin I
    Fertil Steril; 2011 Sep; 96(3):600-4. PubMed ID: 21880277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiles of cumulus cells obtained from women treated with recombinant human luteinizing hormone + recombinant human follicle-stimulating hormone or highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone alone.
    Gatta V; Tatone C; Ciriminna R; Vento M; Franchi S; d'Aurora M; Sperduti S; Cela V; Borzì P; Palermo R; Stuppia L; Artini PG
    Fertil Steril; 2013 Jun; 99(7):2000-8.e1. PubMed ID: 23472943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome.
    Cerrillo M; Pacheco A; Rodríguez S; Gómez R; Delgado F; Pellicer A; Garcia-Velasco JA
    Fertil Steril; 2011 Jun; 95(8):2517-9. PubMed ID: 21269615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression.
    Cavagna M; Maldonado LG; de Souza Bonetti TC; de Almeida Ferreira Braga DP; Iaconelli A; Borges E
    Fertil Steril; 2010 Jun; 94(1):167-72. PubMed ID: 19342035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of luteinizing hormone receptors messenger RNA by human cumulus granulosa cells is in correlation with decreased fertilization.
    Maman E; Yung Y; Kedem A; Yerushalmi GM; Konopnicki S; Cohen B; Dor J; Hourvitz A
    Fertil Steril; 2012 Mar; 97(3):592-8. PubMed ID: 22260850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
    Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
    Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
    Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GnRH agonist vs. hCG for triggering of ovulation--differential effects on gene expression in human granulosa cells.
    Haas J; Ophir L; Barzilay E; Yerushalmi GM; Yung Y; Kedem A; Maman E; Hourvitz A
    PLoS One; 2014; 9(3):e90359. PubMed ID: 24603682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrine Requirements for Oocyte Maturation Following hCG, GnRH Agonist, and Kisspeptin During IVF Treatment.
    Abbara A; Hunjan T; Ho VNA; Clarke SA; Comninos AN; Izzi-Engbeaya C; Ho TM; Trew GH; Hramyka A; Kelsey T; Salim R; Humaidan P; Vuong LN; Dhillo WS
    Front Endocrinol (Lausanne); 2020; 11():537205. PubMed ID: 33123084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GnRH Agonist Triggering Modulates PEDF to VEGF Ratio Inversely to hCG in Granulosa Cells.
    Miller I; Chuderland D; Ron-El R; Shalgi R; Ben-Ami I
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1428-36. PubMed ID: 26308290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Euploidy rates between cycles triggered with gonadotropin-releasing hormone agonist and human chorionic gonadotropin.
    Thorne J; Loza A; Kaye L; Nulsen J; Benadiva C; Grow D; Engmann L
    Fertil Steril; 2019 Aug; 112(2):258-265. PubMed ID: 31103285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of GnRHa ovulation trigger dose on follicular fluid characteristics and granulosa cell gene expression profiles.
    Vuong TNL; Ho MT; Ha TQ; Jensen MB; Andersen CY; Humaidan P
    J Assist Reprod Genet; 2017 Apr; 34(4):471-478. PubMed ID: 28197932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levels of the epidermal growth factor-like peptide amphiregulin in follicular fluid reflect the mode of triggering ovulation: a comparison between gonadotrophin-releasing hormone agonist and urinary human chorionic gonadotrophin.
    Humaidan P; Westergaard LG; Mikkelsen AL; Fukuda M; Yding Andersen C
    Fertil Steril; 2011 May; 95(6):2034-8. PubMed ID: 21377153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Agonist trigger: what is the best approach? Agonist trigger and low dose hCG.
    Humaidan P
    Fertil Steril; 2012 Mar; 97(3):529-30. PubMed ID: 22154368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives.
    Humaidan P; Papanikolaou EG; Kyrou D; Alsbjerg B; Polyzos NP; Devroey P; Fatemi HM
    Reprod Biomed Online; 2012 Feb; 24(2):134-41. PubMed ID: 22197130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of different protocols of ovulation induction, by GnRH agonists and chorionic gonadotropin].
    Parneix I; Emperaire JC; Ruffie A; Parneix P
    Gynecol Obstet Fertil; 2001 Feb; 29(2):100-105. PubMed ID: 11262842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Competence Classification of Cumulus and Granulosa Cell Transcriptome in Embryos Matched by Morphology and Female Age.
    Borup R; Thuesen LL; Andersen CY; Nyboe-Andersen A; Ziebe S; Winther O; Grøndahl ML
    PLoS One; 2016; 11(4):e0153562. PubMed ID: 27128483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.